HEALTH NOTES: People of Color Suffer Disproportionate Impact of COVID-19 Pandemic
A pair of studies released recently show how Black, Hispanic, American Indian, and Alaskan Native people in the United States continue to suffer an outsized share of sickness and death in the ongoing COVID-19 pandemic.
Yale Researchers Take Stem Cells One Step Closer to Replacing Parathyroid Gland Function
Yale investigators have developed a multistep process that models the biological instructions to create parathyroid gland cells from pluripotent stem cells, a significant milestone along the path toward helping people who lack the hormones released by parathyroid glands.
Immune System Variation Can Predict Severe COVID-19 Outcomes
The differing immune system responses of patients with COVID-19 can help predict who will experience moderate and severe consequences of disease, according to a new study by Yale Cancer Center researchers published July 27 in the journal Nature.
Diverse Scholars Institute Supports Underrepresented Faculty
For the past 10 years, Yale University’s Research Education Institute for Diverse Scholars (REIDS) has focused on enhancing the abilities of underrepresented minority faculty in navigating the structural and personal challenges experienced in their early academic careers.
Women's Health in the Time of COVID-19 Webinar
Uncovering how the coronavirus affects the biology of women and men differently is teaching us new ways to fight COVID-19. Identifying how the stress of the pandemic is different for women and men is focusing mental health professionals on risk and resilience. Watch Women’s Health Research at Yale Director Carolyn M. Mazure, Ph.D, and leading immunologist Akiko Iwasaki, Ph.D., in conversation with Yale Medalist Susanna Krentz, '80, as they discuss a major new research finding and next steps in investigating sex differences to advance the health of women and men.
Yale Cancer Center Study Validates Combination Therapy for Aggressive Endometrial Cancer
Yale Cancer Center (YCC) scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer. These results may help to change the standard of care worldwide for the disease. The findings are published today in the journal Clinical Cancer Research.
Stress, Anxiety, or Depression? Treatment Starts With the Right Diagnosis
Wherever constant stress lives, so too does its more agitated and debilitating cousin: anxiety. About 31% of Americans will experience an anxiety disorder at some point in their lives. What’s more, anxiety often goes hand-in-hand with depression.Source: Yale Medicine